1932

Abstract

Cyclooxygenases-1 and -2 (COX-1 and COX-2, also known as prostaglandin H synthases-1 and -2) catalyze the committed step in prostaglandin synthesis. COX-1 and -2 are of particular interest because they are the major targets of nonsteroidal antiinflammatory drugs (NSAIDs) including aspirin, ibuprofen, and the new COX-2-selective inhibitors. Inhibition of the COXs with NSAIDs acutely reduces inflammation, pain, and fever, and long-term use of these drugs reduces the incidence of fatal thrombotic events, as well as the development of colon cancer and Alzheimer's disease. In this review, we examine how the structures of COXs relate mechanistically to cyclooxygenase and peroxidase catalysis and how alternative fatty acid substrates bind within the COX active site. We further examine how NSAIDs interact with COXs and how differences in the structure of COX-2 result in enhanced selectivity toward COX-2 inhibitors.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.biophys.32.110601.141906
2003-06-01
2024-05-12
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.biophys.32.110601.141906
Loading
/content/journals/10.1146/annurev.biophys.32.110601.141906
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error